EdgarLookup

C. H. ROBINSON WORLDWIDE, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that C. H. ROBINSON WORLDWIDE, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
14.8%
Profit Margin
Net income ÷ revenue
11.6%
Return on Assets
Net income ÷ assets
1.74x
Debt-to-Equity
Total liabilities ÷ equity
+4.6%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $3.96B Feb 28, 2018
FY2017 Sep 30, 2017 $3.78B Feb 28, 2018
FY2017 Jun 30, 2017 $3.71B Feb 28, 2018
FY2017 Mar 31, 2017 $3.42B Feb 28, 2018
FY2017 Dec 31, 2016 $3.41B Feb 28, 2018
FY2017 Sep 30, 2016 $3.36B Feb 28, 2018
FY2017 Jun 30, 2016 $3.30B Feb 28, 2018
FY2017 Mar 31, 2016 $3.07B Feb 28, 2018
FY2016 Dec 31, 2015 $3.21B Mar 1, 2017
FY2016 Sep 30, 2015 $3.42B Mar 1, 2017

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $16.23B Feb 13, 2026
FY2025 Dec 31, 2024 $17.72B Feb 13, 2026
FY2025 Dec 31, 2023 $17.60B Feb 13, 2026
FY2024 Dec 31, 2022 $24.70B Feb 14, 2025
FY2023 Dec 31, 2021 $23.10B Feb 16, 2024
FY2022 Dec 31, 2020 $16.21B Feb 17, 2023
FY2019 Dec 31, 2019 $3.79B Feb 19, 2020
FY2019 Sep 30, 2019 $3.86B Feb 19, 2020
FY2019 Jun 30, 2019 $3.91B Feb 19, 2020
FY2019 Mar 31, 2019 $3.75B Feb 19, 2020

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $2.37B Feb 28, 2018
FY2017 Dec 31, 2016 $2.28B Feb 28, 2018
FY2017 Dec 31, 2015 $2.27B Feb 28, 2018
FY2016 Dec 31, 2014 $2.01B Mar 1, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $587.08M Feb 13, 2026
FY2025 Dec 31, 2024 $465.69M Feb 13, 2026
FY2025 Dec 31, 2023 $325.13M Feb 13, 2026
FY2024 Dec 31, 2022 $940.52M Feb 14, 2025
FY2023 Dec 31, 2021 $844.25M Feb 16, 2024
FY2022 Dec 31, 2020 $506.42M Feb 17, 2023
FY2019 Dec 31, 2019 $99.11M Feb 19, 2020
FY2019 Sep 30, 2019 $146.89M Feb 19, 2020
FY2019 Jun 30, 2019 $169.18M Feb 19, 2020
FY2019 Mar 31, 2019 $161.79M Feb 19, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $794.96M Feb 13, 2026
FY2025 Dec 31, 2024 $669.14M Feb 13, 2026
FY2025 Dec 31, 2023 $514.61M Feb 13, 2026
FY2024 Dec 31, 2022 $1.27B Feb 14, 2025
FY2023 Dec 31, 2021 $1.08B Feb 16, 2024
FY2022 Dec 31, 2020 $673.27M Feb 17, 2023
FY2019 Dec 31, 2019 $136.81M Feb 19, 2020
FY2019 Sep 30, 2019 $201.09M Feb 19, 2020
FY2019 Jun 30, 2019 $227.54M Feb 19, 2020
FY2019 Mar 31, 2019 $224.55M Feb 19, 2020

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.06B Feb 13, 2026
FY2025 Dec 31, 2024 $5.30B Feb 13, 2026
FY2025 Dec 31, 2023 $5.23B Feb 13, 2026
FY2024 Dec 31, 2022 $5.95B Feb 14, 2025
FY2023 Dec 31, 2021 $7.03B Feb 16, 2024
FY2022 Dec 31, 2020 $5.14B Feb 17, 2023
FY2021 Dec 31, 2019 $4.64B Feb 23, 2022
FY2020 Dec 31, 2018 $4.43B Feb 19, 2021
FY2019 Dec 31, 2017 $4.24B Feb 19, 2020
FY2018 Dec 31, 2016 $3.69B Feb 25, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.21B Feb 13, 2026
FY2025 Dec 31, 2024 $3.58B Feb 13, 2026
FY2024 Dec 31, 2023 $3.81B Feb 14, 2025
FY2023 Dec 31, 2022 $4.60B Feb 16, 2024
FY2022 Dec 31, 2021 $5.01B Feb 17, 2023
FY2021 Dec 31, 2020 $3.26B Feb 23, 2022
FY2020 Dec 31, 2019 $2.97B Feb 19, 2021
FY2019 Dec 31, 2018 $2.83B Feb 19, 2020
FY2018 Dec 31, 2017 $2.81B Feb 25, 2019
FY2017 Dec 31, 2016 $2.43B Feb 28, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.85B Feb 13, 2026
FY2025 Dec 31, 2024 $1.72B Feb 13, 2026
FY2025 Dec 31, 2023 $1.42B Feb 13, 2026
FY2025 Dec 31, 2022 $1.35B Feb 13, 2026
FY2024 Dec 31, 2021 $2.02B Feb 14, 2025
FY2023 Dec 31, 2020 $1.88B Feb 16, 2024
FY2022 Dec 31, 2019 $1.67B Feb 17, 2023
FY2021 Dec 31, 2018 $1.60B Feb 23, 2022
FY2020 Dec 31, 2017 $1.43B Feb 19, 2021
FY2019 Dec 31, 2016 $1.26B Feb 19, 2020

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 4 Feb 13, 2026
FY2025 Dec 31, 2024 3 Feb 13, 2026
FY2025 Dec 31, 2023 2 Feb 13, 2026
FY2024 Dec 31, 2022 7 Feb 14, 2025
FY2023 Dec 31, 2021 6 Feb 16, 2024
FY2022 Dec 31, 2020 3 Feb 17, 2023
FY2019 Dec 31, 2019 0 Feb 19, 2020
FY2019 Sep 30, 2019 1 Feb 19, 2020
FY2019 Jun 30, 2019 1 Feb 19, 2020
FY2019 Mar 31, 2019 1 Feb 19, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 4 Feb 13, 2026
FY2025 Dec 31, 2024 3 Feb 13, 2026
FY2025 Dec 31, 2023 2 Feb 13, 2026
FY2024 Dec 31, 2022 7 Feb 14, 2025
FY2023 Dec 31, 2021 6 Feb 16, 2024
FY2022 Dec 31, 2020 3 Feb 17, 2023
FY2019 Dec 31, 2019 0 Feb 19, 2020
FY2019 Sep 30, 2019 1 Feb 19, 2020
FY2019 Jun 30, 2019 1 Feb 19, 2020
FY2019 Mar 31, 2019 1 Feb 19, 2020

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $160.87M Feb 13, 2026
FY2025 Dec 31, 2024 $145.76M Feb 13, 2026
FY2024 Dec 31, 2023 $145.52M Feb 14, 2025
FY2023 Dec 31, 2022 $217.48M Feb 16, 2024
FY2022 Dec 31, 2021 $257.41M Feb 17, 2023
FY2021 Dec 31, 2020 $243.80M Feb 23, 2022
FY2020 Dec 31, 2019 $447.86M Feb 19, 2021
FY2019 Dec 31, 2018 $378.62M Feb 19, 2020
FY2018 Dec 31, 2017 $333.89M Feb 25, 2019
FY2018 Dec 31, 2016 $247.67M Feb 25, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.09B Feb 13, 2026
FY2025 Dec 31, 2024 $1.38B Feb 13, 2026
FY2024 Dec 31, 2023 $1.58B Feb 14, 2025
FY2023 Dec 31, 2022 $1.97B Feb 16, 2024
FY2022 Dec 31, 2021 $1.92B Feb 17, 2023
FY2021 Dec 31, 2020 $1.09B Feb 23, 2022
FY2020 Dec 31, 2019 $1.24B Feb 19, 2021
FY2019 Dec 31, 2018 $1.35B Feb 19, 2020
FY2018 Dec 31, 2017 $1.47B Feb 25, 2019
FY2017 Dec 31, 2016 $500.00M Feb 28, 2018